This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pitney Bowes Launches SecLingua To Bring Security Technology To Healthcare

Stocks in this article: PBI

Smith’s healthcare experiences also include co-authoring the first federally funded HMO feasibility study, and participating in healthcare ventures with GTE New Ventures Corporation. He held increasingly responsible management positions with major medical firms, such as Technicon Corporation, American Hospital Supply Corporation and National Patent Development Corporation, where he served as president of its Acme-Chaston subsidiary.

Smith’s credentials as an entrepreneur include: co-founder of CompreMedx Cancer Centers Corporation, co-owner of Kramex Corporation, and co-owner of privately-held New World Healthcare Solutions, Inc. an executive recruiting and online medical education company for the healthcare industry. He also assisted in the turnaround and sale of Medical Sterilization, Inc. In addition, he co-founded Health Excel Management, Inc., and turned around and sold venture-backed HelpMate Robotics, Inc.

Smith has served on the Board of Directors of selected non-profit organizations such as the Connecticut Venture Group (CVG), the Hamden (CT) Chamber of Commerce and the Long Ridge Club, Inc. Smith has been on the faculty of the Albert Einstein College of Medicine of Yeshiva University and Quinnipiac University School of Business and served as the first Executive Director of the Q.U. Entrepreneurship and Small Business Management Institute. Smith was an Adjunct Professor of Marketing and Management at LIM College in New York City, and he holds a BA in Psychology (1970) and an MBA with academic honors (1972) from Boston University.

About Pitney Bowes

Pitney Bowes provides technology solutions for small, mid-size and large firms that help them connect with customers to build loyalty and grow revenue. The company’s solutions for financial services, healthcare, legal, nonprofit, public sector and retail organizations are delivered on open platforms to best organize, analyze and apply both public and proprietary data to two-way customer communications. Pitney Bowes is the only firm that includes direct mail, transactional mail, call centers and in-store technologies in its solution mix along with digital channels such as the Web, email, live chat and mobile applications. Pitney Bowes is a $5.3 billion company with 29,000 employees worldwide. Pitney Bowes: Every connection is a new opportunity™.

About SecLingua, Inc.

SecLingua, Inc. is a privately held corporation based in Shelton, CT that will provide healthcare security information technology under a licensing agreement with Pitney Bowes for its’ Secured Evidence Platform (SEP). Industry sectors that will utilize this state-of-the-art, embedded security technology range from pharmaceutical and instrumentation/equipment manufacturers to service provider organizations such as physician offices, ambulatory care and inpatient facilities and healthcare insurers and third-party payers. The Company is characterized as a developmental stage enterprise with a sole, worldwide license to a unique and differentiated technology.

Copyright Business Wire 2010
2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,906.42 +101.62 0.57%
S&P 500 2,073.62 +2.97 0.14%
NASDAQ 4,773.5410 +8.1610 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs